MoneyWorks4Me

Lasa Supergenerics informs about press release

27 Nov 2017 Evaluate

Lasa Supergenerics has informed about press release of company titled ‘Begins trial production at Unit IV’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..